Who owns ADIAL PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Adial Pharmaceuticals stock

Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Geode Capital Management 164k $58k 138% Sep 2025
 View chart
Vanguard Group 156k $55k 1086% Sep 2025
 View chart
Citadel Advisors 144k $51k 100% Sep 2025
 View chart
Manchester Capital Management 48k $17k 0% Sep 2025
 View chart
BlackRock 28k $9.8k 0% Sep 2025
 View chart
UBS Group 19k $6.6k 51% Sep 2025
 View chart
Two Sigma Securities 13k $4.5k 100% Sep 2025
 View chart
Jane Street 12k $4.4k -50% Sep 2025
 View chart
Hrt Financial 11k $3.0k -41% Sep 2025
 View chart
Private Management Group 10k $3.5k 100% Sep 2025
 View chart
SBI Securities 1.4k $493.067200 6% Sep 2025
 View chart
Tower Research Capital 1.4k $484.021000 -3% Sep 2025
 View chart
Wells Fargo & Company 160.00 $56.992000 0% Sep 2025
 View chart
Abound Wealth Management 27.00 $10.000800 0% Sep 2025
 View chart
Morgan Stanley 9.00 $2.999700 100% Jun 2025
 View chart

Who sold out of Adial Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Two Sigma Investments Jun 2025 11k $3.3k
Stone House Investment Management Jun 2025 2.7k $815.940000